These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 185166)

  • 21. Pu and Am decorporation in beagles: effects of magnitude of initial Ca-DTPA injection upon chelation efficacy.
    Lloyd RD; Jones CW; Taylor GN; Mays CW; Atherton DR
    Radiat Res; 1979 Sep; 79(3):630-34. PubMed ID: 113846
    [No Abstract]   [Full Text] [Related]  

  • 22. Decorporation of Pu and Am from beagles with delayed daily injections of 3,4,3-LICAM(C) or Zn-DTPA.
    Mays CW; Lloyd RD; Jones CW; Bruenger FW; Taylor GN; Durbin PW; White D; Raymond KN
    Health Phys; 1986 Apr; 50(4):530-4. PubMed ID: 3754241
    [No Abstract]   [Full Text] [Related]  

  • 23. Removal of internally deposited transuranium elements by Zn-DTPA.
    Seidel A; Volf V
    Health Phys; 1972 Jun; 22(6):779-83. PubMed ID: 5084010
    [No Abstract]   [Full Text] [Related]  

  • 24. Fetal injury induced by Ca-DTPA in dogs.
    Taylor GN; Mays CW
    Health Phys; 1978 Dec; 35(6):858-60. PubMed ID: 738891
    [No Abstract]   [Full Text] [Related]  

  • 25. Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA.
    Stradling GN; Stather JW; Sumner SA; Strong JC; Lennox AM; Ham SE
    Health Phys; 1984 Apr; 46(4):919-24. PubMed ID: 6706599
    [No Abstract]   [Full Text] [Related]  

  • 26. Decorporation of 241Am in beagles by DTPA.
    Lloyd RD; Mc Farland SS; Taylor GN; Williams JL; Mays CW
    Radiat Res; 1975 Apr; 62(1):97-106. PubMed ID: 235147
    [No Abstract]   [Full Text] [Related]  

  • 27. The removal of zinc from the mouse by polyamincarboxylic acids (CDTA and DTPA) following semichronic zinc ingestion.
    Domingo JL; Llobet JM; Colomina MT; Corbella J
    Vet Hum Toxicol; 1988 Dec; 30(6):524-7. PubMed ID: 3149813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of actinide exposures: a review of Ca-DTPA injections inside CEA-COGEMA plants.
    Grappin L; Berard P; Menetrier F; Carbone L; Courtay C; Castagnet X; Le Goff JP; Neron MO; Piechowski J
    Radiat Prot Dosimetry; 2007; 127(1-4):435-9. PubMed ID: 17940101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metabolism and toxicity of therapeutic chelating agents. 13. Effect of Ca-DTPA on Zn concentration in organs].
    Auth U
    Strahlentherapie; 1973 Oct; 146(4):490-7. PubMed ID: 4786478
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of age on the efficacy of Zn-diethylenetriaminepentaacetic acid therapy for removal of Am and Pu from beagles.
    Lloyd RD; Mays CW; Jones CW; Lloyd CR; Taylor GN; Wrenn ME
    Radiat Res; 1985 Mar; 101(3):451-9. PubMed ID: 3983361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
    Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
    Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decorporation from beagles of a mixture of monomeric and particulate plutonium using Ca-DTPA and Zn-DTPA: dependence upon frequency of administration.
    Lloyd RD; Boseman JJ; Taylor GN; Bruenger FW; Atherton DR; Stevens W; Mays CW
    Health Phys; 1978 Aug; 35(2):217-27. PubMed ID: 701018
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biological action of 239Pu during intake by inhalation and complexon therapy with Zn or Ca DTPA under experimental conditions].
    Siniakov EG; Nifatov AP; Liubchanskiĭ ER; Bazhin AG
    Med Radiol (Mosk); 1988 May; 33(5):58-61. PubMed ID: 3374306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research in the complexon series. I. Detoxicant capacity of Ca-DTPA in experimental chronic plutonium poisoning in rats. II. Influence of the repeated intravenous administration of Ca-DTPA on the elimination of trace elements in rats. 3. Preliminary results of the study, in rats, of the modalities of calcium elimination after Ca45-DTPA injection].
    Truhaut R; Boudène C; Lutz M
    Ann Biol Clin (Paris); 1966; 24(3):419-39. PubMed ID: 5932716
    [No Abstract]   [Full Text] [Related]  

  • 35. [Metabolism and toxicity of therapeutic chelating agents. 14. Effect of DTPA on hematopoiesis].
    Ebel H
    Strahlentherapie; 1975 Apr; 149(4):450-6. PubMed ID: 1135902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
    Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P
    Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined effect of DTPA and citrate on an intramuscular 239Pu deposit in rats.
    Volf V
    Health Phys; 1974 Jul; 27(1):152-3. PubMed ID: 4430623
    [No Abstract]   [Full Text] [Related]  

  • 39. MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy.
    Fritsch P; Grémy O; Hurtgen C; Bérard P; Grappin L; Poncy JL
    Radiat Prot Dosimetry; 2011 Mar; 144(1-4):371-5. PubMed ID: 21131659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radionuclide decontamination. "Prolonged" effect of DTPA].
    Planas-Bohne F
    Strahlentherapie; 1974 Mar; 147(3):315-8. PubMed ID: 4844437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.